Have a feature idea you'd love to see implemented? Let us know!

EXPO Exponent Inc

Price (delayed)

$96.09

Market cap

$4.87B

P/E Ratio

46.87

Dividend/share

$1.1

EPS

$2.05

Enterprise value

$4.75B

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines ...

Highlights
The equity has grown by 10% YoY and by 5% from the previous quarter
EXPO's EPS is up by 3.5% since the previous quarter and by 3.5% year-on-year
EXPO's quick ratio is up by 8% year-on-year but it is down by 3.4% since the previous quarter
The price to earnings (P/E) is 8% higher than the last 4 quarters average of 44.0 but 4.4% lower than the 5-year quarterly average of 49.9
The company's debt has surged by 177% QoQ and by 162% YoY

Key stats

What are the main financial stats of EXPO
Market
Shares outstanding
50.73M
Market cap
$4.87B
Enterprise value
$4.75B
Valuations
Price to book (P/B)
12.38
Price to sales (P/S)
9.07
EV/EBIT
32.92
EV/EBITDA
30.87
EV/Sales
8.76
Earnings
Revenue
$541.71M
EBIT
$144.21M
EBITDA
$153.76M
Free cash flow
$144.41M
Per share
EPS
$2.05
Free cash flow per share
$2.83
Book value per share
$7.76
Revenue per share
$10.6
TBVPS
$13.71
Balance sheet
Total assets
$709.18M
Total liabilities
$315.96M
Debt
$75.3M
Equity
$393.21M
Working capital
$259.5M
Liquidity
Debt to equity
0.19
Current ratio
2.97
Quick ratio
2.8
Net debt/EBITDA
-0.83
Margins
EBITDA margin
28.4%
Gross margin
26.3%
Net margin
19.4%
Operating margin
21.9%
Efficiency
Return on assets
16.2%
Return on equity
28.4%
Return on invested capital
39%
Return on capital employed
25%
Return on sales
26.6%
Dividend
Dividend yield
1.14%
DPS
$1.1
Payout ratio
53.7%

EXPO stock price

How has the Exponent stock price performed over time
Intraday
-1.7%
1 week
-10.27%
1 month
-16.65%
1 year
30.88%
YTD
9.14%
QTD
-16.65%

Financial performance

How have Exponent's revenue and profit performed over time
Revenue
$541.71M
Gross profit
$142.42M
Operating income
$118.78M
Net income
$104.84M
Gross margin
26.3%
Net margin
19.4%
The company's operating margin rose by 4.8% QoQ
The company's operating income rose by 5% QoQ
The company's net margin rose by 3.7% QoQ and by 2.1% YoY
EXPO's gross margin is up by 4% since the previous quarter but it is down by 2.2% year-on-year

Growth

What is Exponent's growth rate over time

Valuation

What is Exponent stock price valuation
P/E
46.87
P/B
12.38
P/S
9.07
EV/EBIT
32.92
EV/EBITDA
30.87
EV/Sales
8.76
The price to earnings (P/E) is 8% higher than the last 4 quarters average of 44.0 but 4.4% lower than the 5-year quarterly average of 49.9
EXPO's EPS is up by 3.5% since the previous quarter and by 3.5% year-on-year
The equity has grown by 10% YoY and by 5% from the previous quarter
The P/B is 4% above the last 4 quarters average of 12.1 but 3.2% below the 5-year quarterly average of 13.0
The price to sales (P/S) is 11% higher than the last 4 quarters average of 8.3 but 9% lower than the 5-year quarterly average of 10.1

Efficiency

How efficient is Exponent business performance
The company's return on invested capital fell by 10% YoY and by 3.7% QoQ
EXPO's ROA is down by 8% YoY
Exponent's return on equity has decreased by 7% YoY
EXPO's return on sales is up by 4.7% year-on-year and by 2.3% since the previous quarter

Dividends

What is EXPO's dividend history
DPS
$1.1
Dividend yield
1.14%
Payout ratio
53.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Exponent financials performed over time
EXPO's total assets is 124% greater than its total liabilities
The company's total liabilities rose by 28% YoY and by 24% QoQ
EXPO's total assets is up by 17% year-on-year and by 13% since the previous quarter
The company's debt is 81% lower than its equity
The company's debt has surged by 177% QoQ and by 162% YoY
The debt to equity has surged by 171% since the previous quarter and by 138% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.